Systematic Review and Network Meta-analysis of Neurostimulation for Painful Diabetic Neuropathy. Diabetes Care 2022;45:2466–2475

  • Rui V. Duarte*
  • , Sarah Nevitt
  • , Sue Copley
  • , Michelle Maden
  • , Cecile C. de Vos
  • , Rod S. Taylor
  • , Sam Eldabe
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e113-e114
JournalDiabetes Care
Volume46
Issue number5
DOIs
Publication statusPublished - May 2023

Bibliographical note

Funding Information:
SCS for PDN and is a co-investigator for the Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain (SENZA-PDN) trial. S.E. has received consultancy fees from Abbott, Boston Scientific Corp., Mainstay Medical, and Medtronic, all unrelated to this work. He has received department research funding from the National Institute of Health Research, Medtronic, and Nevro Corp. No other potential conflicts of interest relevant to this article were reported.

Cite this